<DOC>
	<DOCNO>NCT01891526</DOCNO>
	<brief_summary>To test whether patient hepatic insufficiency tolerate one oral dose 9-cis-retinoic acid test whether metabolism retinoic acid alter .</brief_summary>
	<brief_title>Single Dose 9-cis-retinoic Acid Hepatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>1 . Have biopsy verify hepatic insufficiency 2 . Medically stable . 3 . Ultra sonic examination lever within past 3 month 4 . No pregnancy document woman . use anticonception study 1 month Exclusion criterion : 1 . Odd blood count sample relate hepatic disease 2. encephalopathy ( &gt; grad II ) 3. concomitant treatment pharmaca metabolize CYP3A4 liver . 4 . Cardiac disease 5 . Kidney disease 6 . Epilepsia 7 . Stroke 8 . Esophagal bleed 9 . Severe ascites 10 . HIVpositivity 11 . Psychiatric disorder 12 . Cancer 13. pregnancy lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Metabolisation 9-cis-retinoic acid</keyword>
	<keyword>hepatic patient</keyword>
	<keyword>investigation urine blood sample</keyword>
</DOC>